By David Parsley2022-11-14T11:17:00
UBS Asset Management and Reef Group have completed the purchase of development land that sits alongside GSK’s 1m sq ft research and development scheme in Stevenage.
UBS Asset Management and Reef Group, which bought the site from the pharmaceutical giant, are set to invest up to £900m to develop the 33 acres of land adjacent to GSK’s R&D hub to create a combined campus of 2.5m sq ft of laboratory and office facilities.
You must be logged in to continue
Try Property Week For Free to finish this article.
Sign up now for the following benefits:
To access this article TRY FOR FREE NOW
Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.
Registered users and subscribers SIGN IN here to continue
Site powered by Webvision Cloud